These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 32289272)

  • 21. Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.
    Lustberg MB; Stover DG; Chalmers JJ
    Cancer J; 2018; 24(2):61-64. PubMed ID: 29601331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of
    Cayrefourcq L; Alix-Panabières C
    Expert Rev Mol Diagn; 2020 Sep; 20(9):913-919. PubMed ID: 32856493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
    Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
    Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development.
    Pal A; Shinde R; Miralles MS; Workman P; de Bono J
    Nat Rev Clin Oncol; 2021 Jul; 18(7):454-467. PubMed ID: 33762744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
    Bao Y; Zhang D; Guo H; Ma W
    Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid Biopsy in Solid Malignancy.
    Scarlotta M; Simsek C; Kim AK
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid Biopsy and Lung Cancer.
    Pisapia P; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis.
    Souza VGP; Forder A; Brockley LJ; Pewarchuk ME; Telkar N; de Araújo RP; Trejo J; Benard K; Seneda AL; Minutentag IW; Erkan M; Stewart GL; Hasimoto EN; Garnis C; Lam WL; Martinez VD; Reis PP
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
    Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
    Theil G; Fornara P
    Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breakthrough Technologies: Liquid Biopsy -Chairmen's Introductory Remarks.].
    Nakatani K; Furuta K
    Rinsho Byori; 2016 May; 64(4):392-393. PubMed ID: 29182804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
    Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C
    Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.